VCM
TMO icon

Vision Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Vision Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-325
Closed -$201K – 133
2024
Q3 		$201K Buy
+325
New +$192K 0.03% 127
2022
Q1 		– Sell
-325
Closed -$217K – 111
2021
Q4 		$217K Buy
+325
New +$203K 0.03% 106

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vision Capital Management's TMO Position: Q4 2024 in Review

Vision Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 325 shares — an estimated $201K sold.

Vision Capital Management first reported a position in TMO in Q4 2021 and held it in 2 quarters. The position peaked at $217K in Q4 2021. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Vision Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Vision Capital Management sold 325 Thermo Fisher Scientific shares in Q4 2024, an estimated $201K.
  • Vision Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 2 quarters.
  • Vision Capital Management's Thermo Fisher Scientific position peaked at $217K in Q4 2021.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Vision Capital Management's 13F filing for Q4 2024, filed 27 Jan 2025.